UY31535A1 - METHOD FOR DIAGNOSING COLORECTURAL TUMORS - Google Patents

METHOD FOR DIAGNOSING COLORECTURAL TUMORS

Info

Publication number
UY31535A1
UY31535A1 UY31535A UY31535A UY31535A1 UY 31535 A1 UY31535 A1 UY 31535A1 UY 31535 A UY31535 A UY 31535A UY 31535 A UY31535 A UY 31535A UY 31535 A1 UY31535 A1 UY 31535A1
Authority
UY
Uruguay
Prior art keywords
tumors
colorectural
diagnosing
prognosis
diagnosis
Prior art date
Application number
UY31535A
Other languages
Spanish (es)
Inventor
Gabriel Capella Munar
Simo Schwartz Navarro
Cristina Alemany Boor
Xavier Gregori
Olga Durany Toerk
Elisabet Roselli Vives
Tamara Maes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31535A1 publication Critical patent/UY31535A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a método de diagnostico y/o pronostico de tumores colorrectales que comprende analizar una muestra obtenida de un paciente para determinar el nivel de expresion del gen TNFRSF12A.The present invention relates to a method of diagnosis and / or prognosis of colorectal tumors which comprises analyzing a sample obtained from a patient to determine the level of expression of the TNFRSF12A gene.

UY31535A 2007-12-14 2008-12-15 METHOD FOR DIAGNOSING COLORECTURAL TUMORS UY31535A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200703334 2007-12-14

Publications (1)

Publication Number Publication Date
UY31535A1 true UY31535A1 (en) 2009-03-31

Family

ID=40456727

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31535A UY31535A1 (en) 2007-12-14 2008-12-15 METHOD FOR DIAGNOSING COLORECTURAL TUMORS

Country Status (3)

Country Link
AR (1) AR069697A1 (en)
UY (1) UY31535A1 (en)
WO (1) WO2009077157A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017159739A1 (en) * 2016-03-16 2019-01-31 学校法人同志社 Anti-cancer agent
CN118506863A (en) * 2024-05-11 2024-08-16 青岛可立生物医药有限公司 Colorectal cancer diagnosis and parting equipment and system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
WO2004018648A2 (en) * 2002-08-26 2004-03-04 Case Western Reserve University Methods for treating patients and identifying therapeutics
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer

Also Published As

Publication number Publication date
WO2009077157A1 (en) 2009-06-25
AR069697A1 (en) 2010-02-10

Similar Documents

Publication Publication Date Title
AR083357A1 (en) METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER MASS CANCER METASTASIS
MX2020001156A (en) Method for the prognosis and treatment of cancer metastasis.
EA201600085A1 (en) KIT FOR DETECTION OF SOYO SYNT SYNT0H2 EVENT
BR112014031365A2 (en) methods of detecting disease or conditions
SG11201805531UA (en) Molecular detection/diagnosis reagent for tumor
BR112014030750A2 (en) METHOD FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER METASTASIS
AR095363A1 (en) BIOMARKERS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO PD-1 AND PD-L1
ES2570632T3 (en) In vitro leukocyte elastase inhibitor determination procedure for colorectal cancer
ES2572372T3 (en) Diagnostic method of neurodegenerative diseases based on the measurement of levels or activity of SIRT1
EA201390149A1 (en) METHODS FOR DETECTING DISEASES OR PATHOLOGICAL CONDITIONS USING PHAGOCYTARY CELLS
BR112014025269A2 (en) Method for cancer metastasis prognosis and treatment
CL2007001571A1 (en) GENE INDICATIVE PROFILE OF PROBABILITY INCREASED THAT A PATIENT RESPONDS OR NOT TO IMMUNOTHERAPY; USE OF SUCH PROFILE; PROFILE IDENTIFICATION PROCEDURE; USE OF PROBE TO IDENTIFY DIFFERENTIAL EXPRESSION OF AT LEAST ONE ACT GEN
MX2019000091A (en) Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer.
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
BRPI0920069A8 (en) BIOMARKERS
ATE554389T1 (en) APEX AS A MARKER FOR LUNG CANCER
ES2570631T3 (en) Apolipoprotein AII determination procedure for in vitro diagnosis of colorectal cancer
BR112014031414A2 (en) methods of detecting disease or conditions using circulating diseased cells
BR112015008255A2 (en) Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
EA201490946A1 (en) METHOD OF QUANTITATIVE EVALUATION OF CANCER TREATMENT
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
CY1122360T1 (en) METHOD FOR THE DIAGNOSIS OF NIEMANN-PICK DISEASE
MX2013005796A (en) Methods for detecting neurodegenerative diseases or disorders.
CY1122202T1 (en) DETERMINATION OF RISK FOR ANTIBIOTIC TREATMENT IN PATIENTS SUFFERING FROM A PRIMARY NON-INFECTIOUS DISEASE BY DETERMINATION OF THE PROCALCITONIN LEVEL
NZ729773A (en) Biomarkers for disease progression in melanoma

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180108